Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Illumina
ILMN
|
+$779M |
| 2 |
QuantumScape
QS
|
+$754M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$535M |
| 4 |
Booking.com
BKNG
|
+$399M |
| 5 |
L3Harris
LHX
|
+$322M |
Top Sells
| 1 |
DNKN
Dunkin' Brands Group, Inc.
DNKN
|
+$476M |
| 2 |
Intuitive Surgical
ISRG
|
+$469M |
| 3 |
Home Depot
HD
|
+$454M |
| 4 |
Intel
INTC
|
+$359M |
| 5 |
Salesforce
CRM
|
+$350M |
Sector Composition
| 1 | Technology | 31.01% |
| 2 | Healthcare | 19.61% |
| 3 | Consumer Discretionary | 11.32% |
| 4 | Financials | 9.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Materials Select Sector SPDR Fund
XLB
$5.42B
| $1.95M | ﹤0.01% |
+26,987
| New | +$1.95M |
|
1127
Vanguard Health Care ETF
VHT
$15.7B
| $1.93M | ﹤0.01% |
+8,646
| New | +$1.93M |
|
1128
PG&E
PCG
$33B
| $1.92M | ﹤0.01% |
153,993
+119,160
| +342% | +$1.48M |
|
1129
Cenovus Energy
CVE
$29.5B
| $1.92M | ﹤0.01% |
316,319
-3,036,723
| -91% | -$18.4M |
|
1130
Castle Biosciences
CSTL
$703M
| $1.89M | ﹤0.01% |
28,095
+3,008
| +12% | +$202K |
|
1131
Vanguard Industrials ETF
VIS
$6.04B
| $1.88M | ﹤0.01% |
+11,028
| New | +$1.88M |
|
1132
Supernus Pharmaceuticals
SUPN
$2.55B
| $1.87M | ﹤0.01% |
74,343
+7,216
| +11% | +$182K |
|
1133
ACM Research
ACMR
$1.74B
| $1.81M | ﹤0.01% |
66,870
+12,285
| +23% | +$333K |
|
|
BLSA
1134
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $1.8M | ﹤0.01% |
+163,044
| New | +$1.8M |
|
1135
Concentrix
CNXC
$3.35B
| $1.8M | ﹤0.01% |
+18,185
| New | +$1.8M |
|
1136
Innoviva
INVA
$1.27B
| $1.77M | ﹤0.01% |
143,072
+13,834
| +11% | +$171K |
|
|
INBX
1137
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $1.75M | ﹤0.01% |
+53,213
| New | +$1.75M |
|
1138
Floor & Decor
FND
$9.24B
| $1.75M | ﹤0.01% |
18,880
+11,121
| +143% | +$1.03M |
|
|
PNT
1139
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $1.73M | ﹤0.01% |
123,707
-959
| -0.8% | -$13.4K |
|
1140
Autoliv
ALV
$9.64B
| $1.73M | ﹤0.01% |
18,737
-4,769
| -20% | -$439K |
|
1141
Vornado Realty Trust
VNO
$7.69B
| $1.73M | ﹤0.01% |
46,228
-9,938
| -18% | -$371K |
|
1142
Steel Dynamics
STLD
$19.2B
| $1.72M | ﹤0.01% |
46,710
+927
| +2% | +$34.2K |
|
1143
Chewy
CHWY
$17.3B
| $1.71M | ﹤0.01% |
19,021
-855,916
| -98% | -$76.9M |
|
1144
Pan American Silver
PAAS
$14.9B
| $1.69M | ﹤0.01% |
49,057
-144,594
| -75% | -$4.98M |
|
1145
TripAdvisor
TRIP
$2.01B
| $1.68M | ﹤0.01% |
+58,445
| New | +$1.68M |
|
1146
Vanguard Total International Bond ETF
BNDX
$68.4B
| $1.68M | ﹤0.01% |
28,693
+11,363
| +66% | +$665K |
|
1147
Qualys
QLYS
$4.79B
| $1.68M | ﹤0.01% |
13,765
+754
| +6% | +$91.9K |
|
|
NUAN
1148
DELISTED
Nuance Communications, Inc.
NUAN
| $1.67M | ﹤0.01% |
+37,814
| New | +$1.67M |
|
1149
Vanguard FTSE Emerging Markets ETF
VWO
$98.5B
| $1.66M | ﹤0.01% |
33,188
+13,893
| +72% | +$696K |
|
1150
MoonLake Immunotherapeutics
MLTX
$3.75B
| $1.66M | ﹤0.01% |
+150,000
| New | +$1.66M |
|